BONO, FRANCESCO GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 132
AS - Asia 110
NA - Nord America 105
SA - Sud America 11
AF - Africa 2
Totale 360
Nazione #
US - Stati Uniti d'America 101
SG - Singapore 77
IT - Italia 47
DE - Germania 34
FI - Finlandia 19
BR - Brasile 10
IN - India 8
CN - Cina 7
SE - Svezia 7
EE - Estonia 6
JP - Giappone 6
CA - Canada 4
FR - Francia 4
GB - Regno Unito 4
HK - Hong Kong 4
IE - Irlanda 4
AT - Austria 3
BD - Bangladesh 3
CZ - Repubblica Ceca 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
ES - Italia 1
IQ - Iraq 1
PL - Polonia 1
TR - Turchia 1
VE - Venezuela 1
Totale 360
Città #
Singapore 56
Munich 29
Santa Clara 22
Turku 16
Los Angeles 14
Milan 14
Tokyo 6
Lawrence 5
Princeton 5
Ashburn 4
Dublin 4
Hong Kong 4
Montreal 4
Tremestieri Etneo 4
Adelfia 3
Asti 3
Boardman 3
Chandler 3
Helsinki 3
London 3
Assago 2
Borgia 2
Boston 2
Casoria 2
Chennai 2
Des Moines 2
Ginosa 2
Johannesburg 2
New Delhi 2
Nuremberg 2
Olomouc 2
Palo del Colle 2
Reggio Calabria 2
Shenzhen 2
São Paulo 2
Tashkent 2
Turin 2
Xian 2
Ankara 1
Baghdad 1
Barbacena 1
Bhanga 1
Brasília 1
Brooklyn 1
Buffalo 1
Caracas 1
Chicago 1
Clearwater 1
Criciúma 1
Curitiba 1
Jinan 1
Jinhua 1
Keswick 1
Mumbai 1
Narsingdi 1
New York 1
Norwalk 1
Ourinhos 1
Paris 1
Patna 1
Phoenix 1
Prineville 1
Rome 1
San Francisco 1
Sanford 1
Santa Luzia 1
Santo André 1
Somma Vesuviana 1
Southbury 1
Stockholm 1
Suzano 1
The Dalles 1
Vienna 1
Warsaw 1
Wilmington 1
Totale 278
Nome #
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 44
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 33
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 32
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study 31
Neurological manifestations in patients and disease carriers in an Italian family with osteosclerosis 27
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 26
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 21
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 20
Periventricular white matter changes in idiopathic intracranial hypertension 20
Brainstem changes causing reversible RBD in patients with spontaneous intracranial hypotension: a longitudinal neuroimaging study 19
Parkinsonism during treatment with sodium valproate: A case report 17
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 16
Correction to: A video of best practice recommendations for making botulinum toxin therapy safe during the COVID?19 pandemic (Neurological Sciences, (2021), 42, 9, (3937-3938), 10.1007/s10072-021-05375-z) 16
Effects of alcohol on ocular motor abnormalities in Ramsay-Hunt syndrome 16
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 15
null 13
HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine? 12
Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study 11
Mannitol effectiveness in lowering intracranial pressure in idiopathic intracranial hypertension: A case series 3
Totale 392
Categoria #
all - tutte 4.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 3 4 0 1 0 0 3 0 0
2021/202216 0 1 0 3 4 0 0 3 1 1 3 0
2022/202321 10 0 3 0 0 0 4 1 1 2 0 0
2023/202439 4 11 5 2 4 3 0 0 5 0 2 3
2024/2025268 38 16 8 3 12 37 6 7 31 9 42 59
2025/202637 37 0 0 0 0 0 0 0 0 0 0 0
Totale 392